Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

The HDAC inhibitor trichostatin A inhibits growth of small cell lung cancer cells.

The HDAC inhibitor trichostatin A inhibits growth of small cell lung cancer cells. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • The HDAC inhibitor trichostatin A inhibits growth of small cell lung cancer cells. Abstract Text:

    christopher s plattaChristopher S Platta, greenblatt Greenblatt,muthusamy kunnimalaiyaanMuthusamy Kunnimalaiyaan,herbert chenHerbert Chen,

    BACKGROUND: An estimated 162,460 people will die of lung cancer in the United States in 2006, making it the leading cause of cancer deaths. Small cell lung cancer (SCLC) accounts for 20% of all lung cancers and exhibits aggressive behavior with early metastases. Current treatments yield five-year survival rates of 5 to 10%, indicating a need for novel therapeutic approaches. Histone deacetylase inhibitors (HDACIs) represent a new class of anticancer agents. Trichostatin A (TSA), an HDACI, has been shown to inhibit growth in several cancers. We hypothesized that TSA may inhibit proliferation of SCLC cells. MATERIALS AND METHODS: Human SCLC DMS53 cells were treated with TSA (0 to 400 nM). Light microscopy was used to assess changes in cell morphology. Western analysis was performed for acetylated histone 4 to confirm HDAC inhibition. The effect of TSA treatment on cellular growth was measured by the MTT assay. Finally, levels of BCL-2, cleaved poly(ADP-ribose) polymerase, p21, and p27 proteins were measured to look for induction of cell cycle arrest and/or apoptosis. RESULTS: DMS53 cells treated with TSA underwent dramatic changes in cell appearance. Treated cells assumed round and spindle shapes with distinct cellular borders. Western analysis demonstrated increased levels of acetylated histone 4. TSA treatment resulted in a dose-dependent inhibition of growth. Lastly, elevated p21, p27, and cleaved poly(ADP-ribose) polymerase along with decreased BCL-2 protein levels were observed. CONCLUSIONS: TSA causes morphological differentiation and dose-dependent inhibition of cell growth via cell cycle arrest and subsequent apoptosis. This suggests that TSA and other HDACIs may represent a new potential therapy for patients with SCLC.

    The HDAC inhibitor trichostatin A inhibits growth of small cell lung cancer cells. Publishing Authors By Initials

    cs plattaCS Platta,dy greenblattDY Greenblatt,m kunnimalaiyaanM Kunnimalaiyaan,h chenH Chen,

    For similar neoplasms: neoplasms by site: thoracic neoplasms: respiratory tract neoplasms: lung neoplasms research abstracts see: neoplasms: neoplasms by site: thoracic neoplasms: respiratory tract neoplasms: lung neoplasms research

    PUBMED ID PMID:

    MEDLINE DATE:

    The HDAC inhibitor trichostatin A inhibits growth of small cell lung cancer cells. Journal Published:

    PUBLICATION TYPE: Research Support, N.I.H., Extr

    Journal: The Journal of surgical research

    VOLUME: 142

    Page Numbers: 219-26

    Journal Abbreviation: J. Surg. Res.

    ISSN: 0022-4804

    DAY: 5

    MONTH: 07

    YEAR: 2007

    The HDAC inhibitor trichostatin A inhibits growth of small cell lung cancer cells. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 376340

    The HDAC inhibitor trichostatin A inhibits growth of small cell lung cancer cells. Keywords Mesh Terms:

    KEYWORDS: Lung Neoplasms

    MESH TERMS: pathology

    Chemical & Substance for Abstract: The HDAC inhibitor trichostatin A inhibits growth of small cell lung cancer cells. Information

    Substance Name: Histone Deacetylases

    Registry Number: EC 3.5.1.-

    Grant and Affiliation Information for The HDAC inhibitor trichostatin A inhibits growth of small cell lung cancer cells.

    AFFILIATION: Endocrine Surgery Research Laboratories, Department of Surgery, University of Wisconsin, University of Wisconsin Paul P. Carbone Comprehensive Cancer Center, Madison, Wisconsin, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NIDDK

    GRANT: T35 DK062709

    ACRONYM: DK

    MEDLINETA: J Surg Res

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    The HDAC inhibitor trichostatin A inhibits growth of small cell lung cancer cells Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News